Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Preparing for the Future of HIV/AIDS in Africa: A Shared ...
Released: November 29, 2010
HIV/AIDS is a catastrophe globally but nowhere more so than in sub-Saharan Africa, which in 2009 accounted for 68 percent of cases worldwide and 69 percent of new infections. The IOM recommends that the United States and African nations move toward a strategy of shared responsibility such that these nations are empowered to take ownership of their HIV/AIDS problem and work to solve it.
Rare Diseases and Orphan Products: Accelerating Research ...
Released: October 04, 2010
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development.
Antibiotic Resistance: Implications for Global Health and ...
Released: September 07, 2010
Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant “superbugs.” The IOM’s Forum on Microbial Threats held a public workshop April 6-7 to discuss the nature and sources of drug-resistant pathogens, the implications for global health, and the strategies to lessen the current and future impact of these superbugs.
Extending the Spectrum of Precompetitive Collaboration in ...
Released: July 22, 2010
The IOM’s National Cancer Policy Forum held a workshop February 9-10, 2010, to explore the growing importance of precompetitive collaboration in oncology drug development. Speakers discussed the advantages and challenges of collaborating with competitors to achieve goals with the potential to benefit everyone, and offered lessons learned and best practices to facilitate future precompetitive collaboration.
Mental, Neurological, and Substance Use Disorders in Sub ...
Released: July 08, 2010
Millions of people in sub-Saharan Africa suffer from mental, neurological, and substance use (MNS) disorders, and most do not have the resources to obtain treatment. The Uganda National Academy of Sciences and the IOM hosted a workshop to discuss the state of care for MNS disorders in sub-Saharan Africa.
Enhancing Food Safety: The Role of the Food and Drug ...
Released: June 08, 2010
Foodborne illnesses cause hundreds of thousands of hospitalizations and thousands of deaths in the United States each year. At the request of Congress, the IOM examined gaps in the current food safety system under the purview of the Food and Drug Administration.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic ...
Released: May 12, 2010
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Strategies to Reduce Sodium Intake in the United States ...
Released: April 20, 2010
Population-wide reductions in sodium intake could prevent more than 100,000 deaths annually. In 2008, Congress asked the IOM to recommend strategies for reducing sodium intake to levels recommended in the Dietary Guidelines for Americans. In this report, the IOM concludes that reducing sodium content in food requires new government standards for the acceptable level of sodium.